Detalhe da pesquisa
1.
A new angle for glp-1 receptor agonist: the medical economics argument. Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 [Epub ahead of print].
J Med Econ
; 18(12): 1029-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337323
2.
Venezuelan migrants in Colombia: COVID-19 and mental health.
Lancet Psychiatry
; 7(8): 653-655, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711697